His primary scientific interests are in Cancer research, Pathology, Thyroid, Internal medicine and Thyroid carcinoma. Giovanni Tallini has researched Cancer research in several fields, including Beta-catenin, Anaplastic thyroid cancer, Carcinogenesis, Catenin and Integrin. His Pathology research includes elements of Tumor progression and Karyotype.
His work in Thyroid tackles topics such as Mutation which are related to areas like Mitochondrial DNA. The concepts of his Internal medicine study are interwoven with issues in Immunology, Endocrinology and Oncology. His Thyroid carcinoma research is multidisciplinary, relying on both Cancer, Adenocarcinoma and Gene rearrangement.
Pathology, Cancer research, Thyroid, Internal medicine and Thyroid carcinoma are his primary areas of study. His Pathology research includes themes of Karyotype and Cytogenetics. His Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Gene, Mutation and Exon.
His Thyroid study combines topics in areas such as Phenotype and Cancer. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology, Surgery and Oncology. His research combines Gene rearrangement and Thyroid carcinoma.
His primary areas of study are Internal medicine, Thyroid, Oncology, Cancer research and Gene. He works mostly in the field of Internal medicine, limiting it down to concerns involving IDH1 and, occasionally, Mean age. His research in Thyroid intersects with topics in Persistent Disease, Risk stratification and Pathology.
His Pathology study typically links adjacent topics like Tumor size. Giovanni Tallini interconnects Immunohistochemistry, Tenascin, Who classification, Wild type and Exon in the investigation of issues within Cancer research. His work on Mutation, KRAS and Tumor progression as part of his general Gene study is frequently connected to Hepatic stellate cell activation, thereby bridging the divide between different branches of science.
His main research concerns Thyroid, Cancer research, Internal medicine, Exon and Gene. His Thyroid study incorporates themes from Multivariate analysis and Lymph node, Cohort, Pathology. The concepts of his Pathology study are interwoven with issues in Tumor size, Risk stratification and Univariate analysis.
His study ties his expertise on Thyroid carcinoma together with the subject of Cancer research. Giovanni Tallini combines subjects such as Carcinoma, Endometrial cancer and PTEN with his study of Gene. Giovanni Tallini usually deals with Thyroid cancer and limits it to topics linked to Anaplastic carcinoma and Immunohistochemistry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
Mingzhao Xing;William H. Westra;Ralph P. Tufano;Yoram Cohen.
The Journal of Clinical Endocrinology and Metabolism (2005)
MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
Alba A. Brandes;Enrico Franceschi;Alicia Tosoni;Valeria Blatt.
Journal of Clinical Oncology (2008)
RAS Point Mutations and PAX8-PPARγ Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular Carcinoma
Marina N. Nikiforova;Roy A. Lynch;Paul W. Biddinger;Erik K. Alexander.
The Journal of Clinical Endocrinology and Metabolism (2003)
Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity.
Jeffrey Liu;Bhuvanesh Singh;Giovanni Tallini;Diane L. Carlson.
Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
E. Salloum;Dennis Cooper;G. Howe;J. Lacy.
Journal of Clinical Oncology (1996)
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.
R. Visone;P. Pallante;A. Vecchione;R. Cirombella.
Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
Peng Hou;Dingxie Liu;Yuan Shan;Shuiying Hu.
Clinical Cancer Research (2007)
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
Mingzhao Xing;Ali S. Alzahrani;Kathryn A. Carson;Young Kee Shong.
Journal of Clinical Oncology (2015)
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.
Ginesa Garcia-Rostan;Giovanni Tallini;Agustin Herrero;Thomas G. D’Aquila.
Cancer Research (1999)
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes.
Giovanni Tallini;Massimo Santoro;Mary Helie;Francesca Carlomagno.
Clinical Cancer Research (1998)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: